BILIARY TRACT NEOPLASMS
Clinical trials for BILIARY TRACT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT NEOPLASMS trials appear
Sign up with your email to follow new studies for BILIARY TRACT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests a combination of two drugs, tucatinib and trastuzumab, in people with advanced solid tumors that have HER2 alterations (too much or a different type of HER2 protein). The tumors have spread or cannot be removed by surgery. The main goal is to see if the treatment…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 05:44 UTC
-
Promising combo extends life in Hard-to-Treat bile duct cancer
Disease control OngoingThis study tested adding the immunotherapy drug durvalumab to standard chemotherapy for people with advanced bile duct or gallbladder cancer that cannot be removed by surgery. About 810 participants received either durvalumab plus chemo or a placebo plus chemo. The goal was to se…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
New study tests safer jaundice relief for incurable cancer patients
Symptom relief TerminatedThis study compares two minimally invasive procedures to relieve jaundice in patients with incurable bile duct or pancreatic cancer. The goal is to see which drainage method—connecting the gallbladder or the bile duct to the digestive tract—is safer and works better. About 128 pa…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: NA • Sponsor: Hospital Universitari de Bellvitge • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New study compares two bile duct unblocking methods for cancer patients
Symptom relief TerminatedThis study compares two procedures to relieve a blocked bile duct caused by cancer. About 120 people with pancreatic or bile duct cancer will be randomly assigned to get either a newer ultrasound-guided method or the standard ERCP procedure. The goal is to see which approach has …
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: NA • Sponsor: Hospital Universitari de Bellvitge • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC